Minimising the dose of gonadotrophin releasing hormone agonist [GnRHa] and recombinant follicle stimulating hormone [FSH] used for controlled ovarian hyperstimulation in in-vitro fertilisation
By: by Manal Soliman Elgendy.
Publisher: University of Birmingham
Published: 2001
Place of publication: Birmingham
Language: eng
Number of pages: 204
Notes: Thesis (M.D.) - University of Birmingham, Department of Obstetrics and Gynaecology, Faculty of Medicine and Dentistry.